Joel D. Leverson (AbbVie Inc.)
Session information
Industry Session
IS1-11 Targeting BCL-2 With BH3 Mimetics: Translating Basic Science to Clinical Application
Fri. Oct 11, 2019 1:50 PM - 2:20 PM No.11 (Tokyo International Forum, 5F G502)
Chair: Harumi Mukai(AbbVie GK)
Sponsor: AbbVie GK